Jiang L et al. reported for the first time in 2015 that the LOX-1 immunohistochemical staining score in tumor tissues combined with BMI can predict poor prognosis in patients with NSCLC and squamous cell carcinoma [21]. This evidence concerns the gene OLR1 and non-small cell lung carcinoma.